Shares of BeyondSpring Inc. (NASDAQ:BYSI - Get Free Report) traded down 3.8% during trading on Wednesday . The company traded as low as $1.46 and last traded at $1.49. 43,621 shares traded hands during mid-day trading, an increase of 23% from the average session volume of 35,439 shares. The stock had previously closed at $1.55.
BeyondSpring Stock Down 4.0 %
The business has a fifty day moving average price of $1.70 and a two-hundred day moving average price of $1.86.
BeyondSpring Company Profile
(
Get Free Report)
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
See Also
Before you consider BeyondSpring, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BeyondSpring wasn't on the list.
While BeyondSpring currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
